To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Pertussis toxin (PT) is a protein-based AB5-type exotoxin produced by the bacterium Bordetella pertussis. PT is involved in the colonization of the respiratory tract and the establishment of infection. Research suggests PT may have a therapeutic role in treating a number of common human ailments including hypertension, viral inhibition, and autoimmune inhibition.
Additional recommended knowledge
Mechanism of pathogenesis
PT is an exotoxin with six subunits (named S1 through S5—each complex contains two copies of S4). The subunits are arranged in a A-B structure: the A component is enzymatically active and is formed from the S1 subunit, while the B component is the receptor-binding portion and is made up of subunits S2–S5. The subunits are encoded by ptx genes encoded on a large PT operon that also includes additional genes which encode Ptl proteins: Together these proteins form the PT secretion complex.
PT is released from B. pertussis in an inactive form. When the B subunit binds to a cell membrane receptor, the A subunit (or protomer) becomes activated, perhaps through the action of glutathione and ATP. PT catalyzes the ADP-ribosylation of the α subunits of the heterotrimeric G proteins Gi, Go, and Gt. This prevents the G proteins from interacting with G protein-coupled receptors on the cell membrane, thus interfering with intracellular communication. Since the Gα subunits remain in their GDP-bound, inactive state, they are unable to inhibit adenylyl cyclase or open potassium channels.
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Pertussis_toxin". A list of authors is available in Wikipedia.|